Building on an innovative platform we identify novel carbohydrate targets in pathogenic organisms. We use the technology of glycoengineering to develop vaccines. The first product will be a vaccine to prevent Campylobacter infection in chicken.
Building on an innovative platform we identify novel carbohydrate targets in pathogenic organisms. We use the technology of glycoengineering to develop vaccines. The first product will be a vaccine to prevent Campylobacter infection in chicken.